Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher ...
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback